Of note, patients with lung cancer family history had a significantly higher EGFR mutation rate (64.9% vs. 55.1%, P = 0.045) but the EGFR mutation spectrum was similar with that of the sporadic cases (P = 0.560). This evidence concerns the gene EGFR and lung cancer.